The total nucleated cell dosage of umbilical cord blood (UCB) is an important factor in determining successful allogeneic hematopoietic stem cell transplantation after a minimum human leukocyte antigen donor-recipient match. The northern South American population is in need of a new-generation cord blood bank that cryopreserves only units with high total nucleated cell content, thereby increasing the likelihood of use. Colombia set up a public cord blood bank in 2014; and, as a result of its research for improving high total nucleated cell content, a new strategy for UCB collection was developed.
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BACKGROUND:
The total nucleated cell dosage of umbilical cord blood (UCB) is an important factor in determining successful allogeneic hematopoietic stem cell transplantation after a minimum human leukocyte antigen donor-recipient match. The northern South American population is in need of a new-generation cord blood bank that cryopreserves only units with high total nucleated cell content, thereby increasing the likelihood of use. Colombia set up a public cord blood bank in 2014; and, as a result of its research for improving high total nucleated cell content, a new strategy for UCB collection was developed.
STUDY DESIGN AND METHODS: Data from 2933
collected and 759 cryopreserved cord blood units between 2014 and 2015 were analyzed. The correlation of donor and collection variables with cellularity was evaluated. Moreover, blood volume, cell content, CD341 count, clonogenic capacity, and microbial contamination were assessed comparing the new method, which combines in utero and ex utero techniques, with the conventional strategies.
RESULTS:
Multivariate analysis confirmed a correlation between neonatal birth weight and cell content. The new collection method increased total nucleated cell content in approximately 26% and did not alter precryopreservation and post-thaw cell recovery, viability, or clonogenic ability. Furthermore, it showed a remarkably low microbial contamination rate (1.2%).
CONCLUSION:
The strategy for UCB collection developed at the first Colombian public cord blood bank increases total nucleated cell content and does not affect unit quality. The existence of this bank is a remarkable breakthrough for Latin-American patients in need of this kind of transplantation. U mbilical cord blood (UCB) transplantation is an alternative to marrow (BM) and mobilized peripheral blood (PB) transplantation in candidate patients who lack a suitable compatible donor. 1, 2 The clinical advantages of UCB transplantation compared with BM and PB include faster availability, a lower incidence and severity of graft-versus-host disease (GVHD), higher human leukemic antigen (HLA) mismatch permissiveness, and a higher proportion of primitive hematopoietic stem/progenitor cells, resulting in longer ABBREVIATIONS: BM 5 bone marrow; ClonE 5 clonogenic capacity; Col CBB 5 Colombian UCB bank; HLA 5 human leukemic antigen; PB 5 peripheral blood; TNC 5 total nucleated cell; UC 5 umbilical cord; UCB 5 umbilical cord blood.
From the 1 Cord Blood Bank; and the lasting potency and long-term reconstitution. [2] [3] [4] [5] However, the principal weakness of UCB transplantation is the limited number of cells that can be infused into the patient, which is correlated with delayed neutrophil engraftment, a higher risk of graft failure, and transplantation-related mortality. Most UCB units collected and stored in public banks contain insufficient cell numbers to be transplanted into adult patients, limiting their use in pediatric patients. 3, 6, 7 First-generation UCB banks, defined here as public banks established before the release of the cord blood banking common international standards in 2001, 8 were focused on maintaining a high HLA diversity with relatively low total nucleated cell (TNC) criteria for acceptance. Recent studies have emphasized the importance of high HLA matching and a high TNC content, leading UCB banks to progressively increase their TNC criteria. Low-TNC banked UCB units have a decreased chance of being selected for transplantation, resulting in unnecessary costs. Bart and colleagues 9 demonstrated that discarding over 70% of collected UCB units to avoid storing those with low TNCs resulted in much lower costs per released unit. Therefore, setting high-TNC-threshold acceptance criteria for new-generation UCB banks is more desirable and would increase the usefulness of clinical inventory.
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Several reports have assessed maternal and neonatal clinical data as predictive factors for obtaining high TNC counts, [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] mainly concerning neonatal weight and blood volume. 15, 16, [18] [19] [20] [21] Previous authors have stated that neonates heavier than 3100 g or 3600 g are ideal for obtaining optimal TNC counts for public banking, 13, 27 indicating that performing donor selection based on neonatal birth weight could be a strategy for increasing TNC counts; however, this weight-based selection is almost impossible to achieve, because newborns are weighed after cord and placental manipulation. Therefore, increasing the UCB collection volume may be a more plausible option. Placental infusion is a reported technique for accomplishing this aim, although such manipulation requires highly trained collectors, [28] [29] [30] and strategies employed in public banks must be cost-effective, especially in low-income countries. The first public cord blood bank in the geopolit- In this work, we analyze data from the public Colombian UCB bank (Col CBB), including variables affecting blood volume and TNC counts. We also report a new collection procedure combining in utero and ex utero techniques, which results in significant increases in blood volume and TNC counts and a lower contamination rate. We also demonstrate that this collection method has a minimal impact on cellularity after volume reduction, post-thawing recovery, and the clonogenic capacity (ClonE) before and after cryopreservation.
MATERIALS AND METHODS
Cord blood donor eligibility and collection
This study was conducted at the Col CBB (from Instituto Distrital de Ciencia, Biotecnolog ıa e Innovaci on en Salud [IDCBIS]) using data from UCB units collected between 2014 and 2015 at five public hospitals in the Bogota Capital District (Hospital Occidente de Kennedy, Engativ a, Meissen, La Victoria, Materno Infantil, and Suba). UCB units were collected by dedicated staff, 24 hours a day, 6 days per week, from donors with gestational age older than 34 weeks. We collected the maternal and partner clinical history, focusing on genetic and infectious diseases (anamnestic criteria).
All UCB units were donated by healthy mothers who signed an informed consent form reviewed by the Ethical Committee of the District Secretary of Health. UCB units were obtained only from single-birth, full-term deliveries, and collections were performed in vaginal (n 5 1725) and cesarean (n 5 1380) deliveries. All attempts to collect UCB were successful and were included in the analysis. Clinical data from 17 units were incomplete and thus were excluded from multivariate analysis.
Our novel collection method, referred to as the in/ex utero method, consists of a combination of in utero and ex utero techniques. The in utero technique is done while the placenta is inside the uterus after the delivery of the baby. Traditionally, the umbilical cord (UC) is clamped by the obstetrician until pulsation ceases. The UC and the most distant possible venipuncture site (closest to the clamp) are extensively cleaned with povidone-iodine solution and alcohol. The umbilical vein is punctured with a 16-gauge needle connected to a sterile bag (Terumo Penpol Limited; Pall Corporation, Medical Subsidiary). Blood is drained into the collection bag by gravity until blood flow stops.
The ex utero method involves UCB collection after placental delivery. 31 The placenta is carefully placed on a sterile surface, the nurse turns it to the fetal side and reconstructs the cotyledons, and the umbilical vein is cleaned and punctured as described above. A gentle massage is applied to the placenta to continue draining the blood by gravity in order to increase the blood flow.
In the new technique, the nurse punctures the UC vein before placental delivery; and, when the in utero collection finishes, the UC is clamped above the puncture site to perform the described ex utero method. The placenta is gently massaged alternating with milking the UC. If remaining blood is still visible, then a third puncture may be performed, placing the clamp closer to the placenta. The three methods are done by trained nurses from Col CBB and never by midwives or obstetricians from the hospital. The selection of the collection method that a nurse performs mostly depends on the delivery type and whether there is remaining blood in the placenta after the in utero collection.
UCB units were not collected or were discarded on the basis of the following maternal and neonatal obstetric criteria: maternal infectious diseases, absence of prenatal care, premature membrane rupture, meconium-stained amniotic fluid, maternal fever greater than 388C, preeclampsia, too quick expulsion of the placenta, placental abruption, low Apgar score at birth, low birth weight, and congenital malformations.
Cord blood processing
The collected UCB units were transported to the laboratory at a controlled temperature (range, 18-228C) within the 12 hours after collection. Cellular concentrations were determined using a KX-21N hemocytometer (Roche). Volume reduction of the collected UCB units was performed in a closed system (Biosafe S.A.), with hydroxyethyl starch (HESPAN 6%). The final TNC count, CD341 cell content, and viability were subsequently determined. Clonogenic cultures were performed using MethoCult (Stem Cell Technologies) and were analyzed after 14 days in culture at 378C with 5% CO 2 . The reported data for ClonE depended on calculating the efficiency of colony formation according to the number of CD341 cells seeded per well. The units were cryopreserved with CryoSure-DEX40 (WAK-DEX40-25; Protide) using a controlled freezing curve. The units remained stored in vapor phase nitrogen below 21808C.
The laboratory criteria for excluding UCB from processing were low cellularity (<10 3 10 8 TNCs), damage to the UCB bag, and the presence of blood clots. After cord blood cryopreservation, the exclusion criteria were low ), microbiological contamination, detection of infectious diseases either in the mother or the newborn, hemoglobinopathies, and an absence of maternal blood samples.
CD341 enumeration and viability assessment
Analyses of CD451 and CD341/CD451 total cell numbers and viability were performed using the Stem Cell Enumeration kit (BD Biosciences). FACSCanto software employing the International Society of Hematotherapy and Graft Engineering protocol was used for analysis.
Microbiological assessment, infectious disease testing, and HLA typing Microbiological contamination was determined using residual UCB cultured in anaerobic/F medium and aerobic Peds Plus/F medium (BD BACTEC; BD Bioscience) for 30 days. To eliminate the presence of infectious diseases, maternal and newborn plasma were tested. HLA typing was performed on 591 units by high-resolution sequencing (Histogenetics).
Segment thawing and clonogenic assays
The distal segment of the cryopreserved unit was thawed at 378C. The blood was extracted using a 1-mL syringe and diluted with RPMI complete media (Gibco, Thermo Fisher Scientific). The TNC and the absolute number of viable CD451/CD341 cells were determined using the same methods employed before cryopreservation. Standard numbers of CD341 cells were seeded for clonogenic cultures, as previously described.
Statistical analysis
The data were evaluated using GraphPad Prism software and R statistical software. Multivariate linear regression was performed in R. The D'Agostino-Pearson normality test was employed to assess whether the data presented a normal distribution. For the clonogenic assays, the analysis was performed for paired data.
RESULTS
Setting up the UCB bank in Bogota
In total, 3105 UCB units were collected from January 2014 to December 2015, and 214 and 550 of those units were accepted for cryopreservation in 2014 and 2015, respectively. Only 2933 units had all of the data necessary for analysis (Tables 1 and 2 ). The percentage of UCB units accepted for banking (n 5 764) was 24.4%. Relevant clinical data on neonatal weight, maternal age, and gestational age are provided in Table 1 . Correlation of TNC counts with obstetrical variables was assessed in multivariate linear analysis. This assessment also included delivery type and collection method. We observed that the TNC counts showed significant, positive correlations only with neonatal weight (p < 0.0001), gestational age (p 5 0.0003), cesarean delivery (p < 0.0001), and in/ex utero collection method (p < 0.0001). An analysis of variance inflation factors confirmed that there was no multicollinearity between variables.
Descriptive statistics for the UCB bag weight, total UCB volume, pre-reduction and post-reduction TNC counts, and total CD341 and CD451 cell numbers in the collected and processed units are listed in Table 2 . The mean total UCB volume (without anticoagulant) was 59 mL, and the pre-reduction TNC count was 8 3 10 
The in/ex utero collection method increases the TNC count
The in/ex utero technique was performed exclusively during cesarean sections in 2014. The mean 6 standard deviation UCB volume collected in/ex utero was 67.86 6 29.71 mL, which was 23% higher than the volume collected with the in utero technique (51.73 6 24.86 mL) and 20% higher compared than that collected with the ex utero technique (54.24 6 26.51 mL; p < 0.0001) (Fig. 1a) .
Comparison of the TNC counts from UCB units collected in utero (7.5 6 4. ; p < 0.0001) (Fig. 1c) . Because of the increase in TNCs obtained through in/ex utero collection, there was a higher proportion of banked UCB units collected by this method compared with the in utero method (33.2 vs. 20.1%; chi-square test; p < 0.0001) (Fig.  1d) . We also observed that the percentage of cryopreserved UCB units collected during cesarean sections was greater than that collected during vaginal deliveries (31.7 vs. 19.0%; chi-square test; p < 0.0001) (Fig. 1e) , as expected.
Recovery rates and quality control precryopreservation in UCB collected in/ex utero Because placental massage may affect cellular recovery or viability when performing the in/ex utero technique, we determined its impact on UCB quality by comparing relevant variables after volume reduction. We found no significant differences between the in utero and in/ex utero methods in terms of post-reduction TNC counts (p 5 0.4766), total viable CD451 cells (p 5 0.5741), total viable CD341 cells (p 5 0.5741), or the percentage of CD341 cells among TNCs (p 5 0.5684). We also verified that there were no significant differences in ClonE for units collected through in utero versus in/ex utero methods (p 5 0.7489) (Fig. 1f) .
Recovery rates and quality control postcryopreservation in UCB collected in/ex utero We determined whether the collection method had an impact on UCB quality after cryopreservation. For these experiments, we used nonoptimal, nonclinical cryopreserved UCB units grouped by collection method to assess the effects on post-thaw cellular parameters. UCB units containing 8.1 6 1.4 3 10 8 TNCs and 0.27 6 0.18% CD341 cells were paired according to pre-cryopreservation cell numbers. When the post-thaw TNC count was assessed by collection method, we observed no significant differences in recovery levels between the groups (69.1 6 27.2% for in utero collection vs. 74.2 6 16.1% for in/ex utero collection; p > 0.9) (Fig. 2a) . The percentage recovery and viability of CD341 cells also did not differ significantly (p 5 0.6875 and p 5 0.8438, respectively) (Fig.  2b,c) . There was no difference in ClonE between the UCB units collected in utero and in/ex utero (p 5 0.8125) (Fig.  2d ). In conclusion, the critical parameters of stored UCB units collected in/ex utero did not differ significantly from those obtained using conventional techniques, even when assessing UCB units with low cell counts.
UCB units collected in/ex utero exhibit lower microbial contamination
An important concern regarding the use of the new collection technique for UCB is the likelihood of microbial contamination caused by ex utero placental manipulation. First, we compared the microbial contamination rate in UCB units collected by both methods in cesarean deliveries during 2014. We found that the percentages of positive microbial contamination were 4.2% and 5.6% (Fisher's exact test; p 5 0.8498) for in utero-collected and in/ex utero-collected units, respectively. Subsequently, we compared the units collected with the two methods during 2015. Surprisingly, 6.0% of in utero-collected units were contaminated, in contrast to 1.2% of in/ex utero-collected units (p 5 0.0003) (Fig. 3a) . Thus, there is a remarkable reduction in the contamination rate between UCB units collected with the in/ex utero method, supporting its extensive use during both delivery types.
The in/ex utero method does not result in more cross-contamination between maternal and neonatal blood
Finally, we assessed the potential cross-contamination of UCB with maternal blood resulting from the application of positive pressure to the placenta when performing the in/ex utero collection technique. 32, 33 To evaluate this possibility, we compared discrepancies in Rh and ABO group classifications in units obtained via the in utero and in/ex utero techniques. When all cryopreserved units were evaluated, we found three with double ABO and Rh group populations, two of which were collected in/ex utero (0.008% of 372 cryopreserved units) and one of which was collected in utero (0.0055% of 358 cryopreserved units; Fisher's exact test; p 5 1.00) (Fig. 3b) . Interestingly, none of these samples showed ambiguities in the allele typing of HLA-A, HLA-B, HLA-C, HLA-DR, or HLA-DQ loci. Therefore, the in/ex utero collection method does not promote cross-contamination between maternal and newborn blood.
DISCUSSION
In this study, we analyzed data from the Col CBB during its first operating period. to the multiethnic migration history of the country. 34 Despite the lack of established policy and legislation regarding a national BM donor registry, support from the District and National Governments led to the implementation of a public UCB bank in Colombia.
In this study, we analyzed variables that could help to optimize the donor selection process to obtain higher TNCs. We confirmed that maternal age was not related to TNCs, as previous reports have shown, 12, 16, 19 whereas gestational age and neonatal weight exhibited a significant correlation with TNC counts. 14, 15, 18, 20, 21 Numerous reports have indicated the significant effect of higher neonatal weight on TNC recovery, because a higher cell number is a consequence of the greater blood volume of a heavier baby. 15, 16, [20] [21] [22] [23] 27, 35 The mean weight of Colombian newborns (3113 g) is considerably lower than the weights reported in Europe, 17, 18, 23, 35 the United States, 16, 27, 36 and Taiwan. 13, 21 This situation represents a disadvantage, because the ideal weight for obtaining samples with higher cellularity is 3600 g. 13 The delayed cord-clamping practice employed in Colombia also affects the obtained blood volume. 37 These facts prompted us to develop a UCB collection method for obtaining the largest possible blood volume. The improvement in the quality of banked UCB units from modifying the collection method has been previously reported. 26, 30, 31, 38 For instance, in utero collection is mainly performed in vaginal deliveries to take advantage of the facilitation of blood efflux by uterine contractions, whereas ex utero collection is performed in cesarean sections, in which there is higher sterility. 31 Perfusion with saline solution is another reported method. [28] [29] [30] Our data demonstrate that the developed in/ex utero collection technique significantly increases blood volume and TNCs compared with the in utero and ex utero methods. Although this method involves placental manipulation, it may be performed by a single trained collector and does not increase the risk of contamination. An apparently similar in/ex utero collection method was described in a recently published abstract, 39 and the technique demonstrated higher values for cord blood volume and TNCs; unfortunately, the procedure was not exhaustively described. We presume that it was different from ours, because it involved two types of cord blood collection personnel compared with our dedicated-staff model. It is desirable for a UCB bank to increase the acceptance rate of units for potential clinical application. This is a measure of banking efficiency, which is important to optimize costs. Here, we show that the proportion of banked units resulting from in/ex utero collection was significantly higher than the proportions obtained using classic techniques. Furthermore, the contamination rate was significantly lower in the in/ex utero-collected versus the in utero-collected UCB. Considering these positive attributes together, we conclude that the in/ex utero collection method could help to optimize costs for UCB banking.
Several authors have reported that UCB units collected during cesarean section exhibit lower cellularity and higher blood volumes compared with units collected from vaginal deliveries. 12, 15, 18, 19, 21, 24, 26 In contrast, we observed significantly higher TNC counts in units collected from cesarean sections than in units collected from vaginal deliveries and, consequently, a higher proportion of cryopreserved units collected during cesarean sections. However, because the in/ex utero method was preferentially performed in cesarean sections compared with vaginal deliveries (673 vs. 127 collections, respectively), we assume that the higher cryopreservation rate was due to the collection method and not the type of delivery.
To evaluate the possible disadvantages of the in/ex utero method compared with the in utero collection technique, we assessed cellular contents and viability before and after cryopreservation. Moreover, we analyzed the microbial contamination risk and the likelihood of maternal and neonatal blood cross-contamination. There were no differences in the post-thaw recovery, viability, or clonogenic ability of TNC and CD341 cells. In addition, blood cross-contamination was similar between the two techniques, and the microbial contamination rate was surprisingly low for the in/ex utero method. We assume that this exceptional finding could be explained not only by the technique but also by the higher proportion of in/ ex utero collections performed in cesarean sections. These procedures have different contamination probabilities, because the UC passes through a canal rich in microbes in vaginal deliveries, and the procedures are performed in rooms with different disinfection protocols.
The existence of a public UCB bank with an inventory of units exhibiting a mean TNC count of 11 3 10 8 and a mean CD341 cell count of 5 3 10 6 , using a new collection technique that improves the UCB quality, is a remarkable breakthrough for Latin-American patients in need of an allogeneic hematopoietic stem/progenitor cell transplant. To the best of our knowledge, this is the first study reporting the implementation of a public cord blood bank in the Andean states as well as a new collection method that increases blood volume and cellularity.
